<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Bioclonetics Immunotherapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Bioclonetics Immunotherapeutics, Inc.

    BioClonetics Immunotherapeutics is a biotechnology company with a proprietary methodology and expertise for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy, targeting and neutralizing infectious diseases including HIV, influenza, tetanus and diphtheria.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Reg CF
    • PLATFORM TYPE
      StartEngine
    • RAISED AMOUNT
      $255,600
    • PRE-MONEY EVAULATION
      $520,701.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Charles S. Cotropia
    • FOUNDED
      2009
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Coloplast AS

    Coloplast AS

    Coloplast develops products and services that make life easier for people with ver...

    Coloplast develops products and services that m...

    Filing Type:    PU
    Medigus Ltd.

    Medigus Ltd.

    Medigus is a medical device company specializing in developing minimally invasive ...

    Medigus is a medical device company specializin...

    Filing Type:    PU
    Organigram Holdings Inc.

    Organigram Holdings Inc.

    Organigram Holdings Inc. NASDAQ (OGI) TSX (OGI), is the parent company of Organigr...

    Organigram Holdings Inc. NASDAQ (OGI) TSX (OGI)...

    Filing Type:    PU
    HTG Molecular Diagnostics, Inc.

    HTG Molecular Diagnostics, Inc.

    HTG Molecular Diagnostics, Inc. ("HTG") is a provider of instruments, reagents, an...

    HTG Molecular Diagnostics, Inc. ("HTG") is a pr...

    Filing Type:    PU
    InnaMed, Inc.

    InnaMed, Inc.

    InnaMed is developing a comprehensive care management platform. Our team is develo...

    InnaMed is developing a comprehensive care mana...

    Amount Raised:    $1,070,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Roche Holding Ltd

    Roche Holding Ltd

    Together, a potent new drug and a blood test to guide its use can be a life change...

    Together, a potent new drug and a blood test to...

    Filing Type:    PU
    H&G Science LLC

    H&G Science LLC

    H&G Science aims to facilitate the safe and effective treatment of diseases, takin...

    H&G Science aims to facilitate the safe and eff...

    Amount Raised:    $24,000.00
    Filing Type:    CF
    World Health Organization

    World Health Organization

    The World Health Organization is an international organization that directs and co...

    The World Health Organization is an internation...

    Filing Type:    PR
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    Sinovac Biotech, Ltd.

    Sinovac Biotech, Ltd.

    Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on th...

    Sinovac Biotech Ltd. is a China-based biopharma...

    Filing Type:    PU
    Novelion Therapeutics Inc.

    Novelion Therapeutics Inc.

    Novelion Therapeutics Inc. (“Novelion"), headquartered in Vancouver, British Col...

    Novelion Therapeutics Inc. (“Novelion"), head...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.